Turkish Archives of Pediatrics is a prominent Open Access journal dedicated to advancing the field of pediatrics, published by AVES. Launched in 2019, the journal provides an essential platform for researchers, clinicians, and students to disseminate innovative research findings, reviews, and clinical studies focused on child health. Operating out of Turkey, this journal has carved out a notable position in the academic landscape, currently holding a Q3 quartile ranking in Pediatrics, Perinatology, and Child Health as of 2023. With a Scopus rank of #179 out of 330 in its category, the journal ensures significant visibility for its authors, contributing to a wider understanding of pediatric health issues. Its open access policy promotes unrestricted dissemination of vital pediatric research, making it accessible to a global audience and enhancing collaborative efforts across borders. Researchers and professionals looking to stay at the forefront of pediatric advances will find Turkish Archives of Pediatrics to be an invaluable resource.

NEUROTOXICOLOGY AND TERATOLOGY, published by PERGAMON-ELSEVIER SCIENCE LTD, is a premier journal dedicated to advancing knowledge in the critical fields of neuroscience and toxicology. With a focus on the mechanisms of neurotoxic effects and developmental disturbances, this journal serves as a vital resource for researchers, practitioners, and students committed to understanding the complexities of neurotoxicology and its implications for human health. The journal boasts a solid impact factor and holds esteemed quartile rankings, being classified as Q3 in both Cellular and Molecular Neuroscience and Developmental Neuroscience, and Q2 in Toxicology as of 2023. Despite being a subscription-based journal, NEUROTOXICOLOGY AND TERATOLOGY is recognized for its authoritative peer-reviewed articles that encompass a broad spectrum of research from 1987 to 2024, making it indispensable for those who seek in-depth knowledge and current scientific discourse in the field. Its impactful position within Scopus rankings underlines its importance, with notable placement across various neuroscience and toxicology categories.

HYPERTENSION RESEARCH, published by SpringerNature, serves as a premier platform in the field of Cardiology and Cardiovascular Medicine, Internal Medicine, and Physiology. Since its inception in 1992, the journal has built a substantial reputation, currently ranked in the second quartile (Q2) across several categories in 2023, reflecting its influence and high-quality contributions to medical research. With a focus on hypertension, the journal aims to disseminate vital research findings, clinical studies, and innovative treatment strategies to a diverse audience of researchers, healthcare professionals, and students, fostering knowledge exchange in the management of hypertensive conditions. Although it is not an Open Access journal, it offers comprehensive access to its extensive archive of valuable resources, ensuring that critical advancements in the understanding of hypertension are both accessible and impactful. HYPERTENSION RESEARCH is not only essential for those directly involved in cardiovascular and internal medicine practices but also for interdisciplinary scholars who are looking to explore the intersections of physiology and other biomedical fields in their work.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, published by Springer, is a prestigious peer-reviewed journal dedicated to advancing the fields of cancer research and clinical oncology. With an impact factor reflecting its significance within the academic community, the journal operates under a rigorous quality standard and offers a wealth of knowledge spanning from 1979 and continuing through 2025. With its comprehensive scope, it encompasses a wide array of topics including novel therapeutic strategies, clinical trials, and cutting-edge research methodologies, making it an essential resource for researchers, practitioners, and students alike. The journal’s category quartiles highlight its competitive edge, ranking Q2 in Cancer Research and Q1 in Medicine (miscellaneous) as of 2023. This positioning underscores its role at the forefront of oncology discourse. Through this journal, contributors and readers alike engage with impactful research that informs clinical practices and enhances patient care in oncology. Access to the journal’s content, although not open access, ensures curated and high-quality insights available to the academic and professional community.

The Journal of Maternal-Fetal & Neonatal Medicine, published by Taylor & Francis Ltd, is a leading multidisciplinary journal focused on the critical fields of obstetrics, gynecology, pediatrics, and perinatology. Since its inception, this journal has offered a platform for the dissemination of pioneering research and innovative clinical practices, bridging knowledge gaps and informing the future of maternal and neonatal health. With a commendable 2023 impact factor that places it in the Q2 category of both Obstetrics and Gynecology and Pediatrics, Perinatology and Child Health, it stands at the forefront of scientific discourse, attracting a global readership. The journal aims to provide high-quality articles that contribute significantly to patient care, clinical practices, and policy-making, ensuring relevance and applicability to both researchers and healthcare professionals. With comprehensive access options and an emphasis on the convergence of emerging research trends, the Journal of Maternal-Fetal & Neonatal Medicine remains an invaluable resource for anyone dedicated to advancing the health of mothers and their newborns.

Research in Cardiovascular Medicine is a renowned open-access journal published by Wolters Kluwer Medknow Publications, dedicated to advancing knowledge in the swiftly evolving field of cardiovascular health. With an ISSN of 2251-9572 and E-ISSN of 2251-9580, this journal serves as a vital platform for researchers and professionals to share their findings, explore innovative treatments, and discuss current trends in cardiovascular care. Since transitioning to open access in 2013, it has democratized access to high-quality research, ensuring that vital information reaches healthcare practitioners and academia alike. The journal’s commitment to rigorous peer review and its emphasis on cutting-edge research contribute significantly to improving patient outcomes and addressing the global burden of cardiovascular diseases. By publishing original articles, review papers, and clinical studies, Research in Cardiovascular Medicine plays a crucial role in shaping the future of cardiovascular research and education, appealing to a wide audience of researchers, professionals, and students striving to make meaningful contributions to this critical field.

Environmental Health Perspectives (EHP) is a premier open-access journal published by the U.S. Department of Health and Human Services, Public Health Science, dedicated to publishing rigorous and impactful research in the field of environmental health. Since its inception in 1972, EHP has become a leading platform for disseminating knowledge on the interactions between the environment and human health, making significant contributions to the fields of toxicology and public health. With an impressive impact factor and a Q1 ranking in both Health, Toxicology and Mutagenesis and Public Health, Environmental and Occupational Health categories, EHP ranks among the top journals globally, reflecting its high citation and visibility within the academic community. Researchers, professionals, and students alike will find a wealth of vital information within its pages, as EHP covers a wide array of topics related to environmental exposures, health outcomes, and policy implications. Furthermore, EHP engages with a global audience through its commitment to open access, ensuring that critical research is available to all, enhancing the collective understanding of environmental health issues since 1972.

World Journal of Pediatric Surgery, published by the esteemed BMJ Publishing Group, is a pivotal open-access journal that has been disseminating high-quality research in the fields of pediatrics and surgical sciences since 2018. With an E-ISSN of 2516-5410, this journal serves as a valuable resource for researchers, healthcare professionals, and students dedicated to improving surgical outcomes in pediatric populations. Located in the United Kingdom, it has quickly established its importance within the academic community, achieving a Q3 ranking in both Pediatrics, Perinatology and Child Health and Surgery in the 2023 category quartiles. Notably, the journal's impact is reflected in its Scopus ranks, positioning it within the 42nd and 37th percentiles for surgery and pediatrics, respectively. As it continues to converge research findings through 2024, the World Journal of Pediatric Surgery aims to enhance collaborative efforts and foster innovative practices that advance the care of children undergoing surgical interventions.

CONGENITAL ANOMALIES is a notable journal published by WILEY, dedicated to advancing the understanding of congenital disorders and anomalies through high-quality research and clinical insights. With an ISSN of 0914-3505 and an E-ISSN of 1741-4520, this journal has been a key resource for professionals in the fields of pediatrics, embryology, and developmental biology since its inception in 1973, although coverage discontinued in Scopus after 2019 due to evolving standards in publication. The journal is ranked in the 48th percentile in the domain of pediatrics, as well as in the 26th and 14th percentiles respectively for embryology and developmental biology, placing it among respected publications in its category. Although it does not currently offer open access options, its contributions remain vital for researchers, healthcare professionals, and students seeking up-to-date information on congenital anomalies, their origins, and potential interventions. With a commitment to fostering knowledge in this critical area of health science, CONGENITAL ANOMALIES continues to play an important role in the intersection of scientific research and clinical practice.

BULLETIN DU CANCER is a pivotal academic journal dedicated to the field of oncology, providing a platform for innovative research and insights into cancer treatment and diagnostics. Published by Elsevier Masson, Corp Off in France, this journal has been a part of the scientific community since 1966, and is committed to sharing critical findings that influence clinical practices and improve patient outcomes. Despite its recent rankings placing it in the Q4 category for Cancer Research and Q3 for Hematology and other related fields, BULLETIN DU CANCER remains essential for those interested in the latest developments in cancer biology and treatment methodologies. With an emphasis on both basic and clinical research, it serves as a valuable resource for researchers, healthcare professionals, and students seeking to deepen their understanding in various dimensions of oncology. This journal is particularly relevant as it continues to spotlight emerging research trends and supports the global imperative to combat cancer more effectively.